MiR-492 impairs the angiogenic potential of endothelial cells

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 8, 2013, Pages 1006-1015

  Patella, Francesca ^a   Leucci, Eleonora ^b   Evangelista, Monica ^a   Parker, Brian ^c   Wen, Jiayu ^b,c   Mercatanti, Alberto ^a   Rizzo, Milena ^a   Chiavacci, Elena ^a   Lund, Anders H ^b   Rainaldi, Giuseppe ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Endothelial cell; eNOS; MicroRNA

Indexed keywords

3 PHOSPHOINOSITIDE DEPENDENT PROTEIN KINASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LUCIFERASE; MICRORNA; MIRN492 MICRORNA, HUMAN; PDPK1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SP1;

3' UNTRANSLATED REGION; ARTICLE; CELL STRAIN HCT116; ENDOTHELIUM CELL; ENOS; ENZYME ASSAY; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; HUMAN; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PROTEIN BINDING; UMBILICAL VEIN ENDOTHELIAL CELL;

ENDOTHELIAL CELL; ENOS; MICRORNA;

3' UNTRANSLATED REGIONS; 3-PHOSPHOINOSITIDE-DEPENDENT PROTEIN KINASES; ENDOTHELIAL CELLS; ENZYME ASSAYS; GENE EXPRESSION REGULATION; HCT116 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; LUCIFERASES; MICRORNAS; NEOVASCULARIZATION, PATHOLOGIC; NITRIC OXIDE SYNTHASE TYPE III; PROTEIN BINDING; SP1 TRANSCRIPTION FACTOR; TRANSFECTION;

EID: 84888199307     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12085     Document Type: Article

References (28)

1. Ding Y, Vaziri ND, Coulson R, et al. Effects of simulated hyperglycemia, insulin, and glucagon on endothelial nitric oxide synthase expression. Am J Physiol Endocrinol Metab. 2000; 279: E11-7.
2. Patella F, Rainaldi G. MicroRNAs mediate metabolic stresses and angiogenesis. Cell Mol Life Sci. 2012; 69: 1049-65.
3. Hamuro M, Polan J, Natarajan M, et al. High glucose induced nuclear factor kappa B mediated inhibition of endothelial cell migration. Atherosclerosis. 2002; 162: 277-87.
4. Varma S, Lal BK, Zheng R, et al. Hyperglycemia alters PI3k and Akt signaling and leads to endothelial cell proliferative dysfunction. Am J Physiol Heart Circ Physiol. 2005; 289: H1744-51.
5. Orom UA, Lund AH. Experimental identification of microRNA targets. Gene. 2010; 451: 1-5.
6. Poliseno L, Tuccoli A, Mariani L, et al. MicroRNAs modulate the angiogenic properties of HUVEC. Blood. 2006; 108: 3068-71.
7. Pitto L, Rizzo M, Simili M, et al. miR-290 acts as a physiological effector of senescence in mouse embryo fibroblasts. Physiol Genomics. 2009; 39: 210-8.
8. Rainer J, Sanchez-Cabo F, Stocker G, et al. CARMAweb: comprehensive R- and bioconductor-based web service for microarray data analysis. Nucleic Acids Res. 2006; 34: W498-503.
9. Orom UA, Lund AH. Isolation of microRNA targets using biotinylated synthetic microRNAs. Methods. 2007; 43: 162-5.
10. Nicoli S, Presta M. The zebrafish/tumor xenograft angiogenesis assay. Nat Protoc. 2007; 2: 2918-23.
11. Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 2008; 14: 844-52.
12. Cummins JM, He Y, Leary RJ, et al. The colorectal microRNAome. Proc Natl Acad Sci USA. 2006; 103: 3687-92.
13. Rizzo M, Mariani L, Cavallini S, et al. The over-expression of miR-34a fails to block DoHH2 lymphoma cell proliferation by reducing p53 via c-MYC down-regulation. Nucleic Acid Ther. 2012; 22: 283-8.
14. Zhang R, Min W, Sessa WC. Functional analysis of the human endothelial nitric oxide synthase promoter. Sp1 and GATA factors are necessary for basal transcription in endothelial cells. J Biol Chem. 1995; 270: 15320-6.
15. Alessi DR, James SR, Downes CP, et al. Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha. Curr Biol. 1997; 7: 261-9.
16. Dimmeler S, Fleming I, Fisslthaler B, et al. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999; 399: 601-5.
17. Primo L, di Blasio L, Roca C, et al. Essential role of PDK1 in regulating endothelial cell migration. J Cell Biol. 2007; 176: 1035-47.
18. Herrera BM, Lockstone HE, Taylor JM, et al. MicroRNA-125a is over-expressed in insulin target tissues in a spontaneous rat model of Type 2 Diabetes. BMC Med Genomics. 2009; 2: 54.
19. Wang XH, Qian RZ, Zhang W, et al. MicroRNA-320 expression in myocardial microvascular endothelial cells and its relationship with insulin-like growth factor-1 in type 2 diabetic rats. Clin Exp Pharmacol Physiol. 2009; 36: 181-8.
20. Caporali A, Emanueli C. MicroRNA-503 and the extended microRNA-16 family in angiogenesis. Trends Cardiovasc Med. 2011; 21: 162-6.
21. Li Y, Song YH, Li F, et al. MicroRNA-221 regulates high glucose-induced endothelial dysfunction. Biochem Biophys Res Commun. 2009; 381: 81-3.
22. Togliatto G, Trombetta A, Dentelli P, et al. MIR221/MIR222-driven post-transcriptional regulation of P27KIP1 and P57KIP2 is crucial for high-glucose- and AGE-mediated vascular cell damage. Diabetologia. 2011; 54: 1930-40.
23. Landgraf P, Rusu M, Sheridan R, et al. A mammalian microRNA expression atlas based on small RNA library sequencing. Cell. 2007; 129: 1401-14.
24. Griffiths-Jones S, Grocock RJ, van Dongen S, et al. miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 2006; 34: D140-4.
25. Raver-Shapira N, Marciano E, Meiri E, et al. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell. 2007; 26: 731-43.
26. Schepeler T, Reinert JT, Ostenfeld MS, et al. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res. 2008; 68: 6416-24.
27. Loeb GB, Khan AA, Canner D, et al. Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol Cell. 2012; 48: 760-70.
28. Liang H, Li WH. Lowly expressed human microRNA genes evolve rapidly. Mol Biol Evol. 2009; 26: 1195-8.